Abstract:Background: Inherited retinal dystrophies (IRD) are one of the main causes of incurable blindness worldwide. IRD are caused by mutations in genes that encode essential proteins for the retina, leading to photoreceptor degeneration and loss of visual function. IRD generates an enormous global financial burden due to the lack of understanding of a significant part of its pathophysiology, molecular diagnosis, and the near absence of non-palliative treatment options. Patient-derived induced pluripotent stem cells (iPSC) for IRD seem to be an excellent option for addressing these questions, serving as exceptional tools for in-depth studies of IRD pathophysiology and testing new therapeutic approaches. Methods: From a cohort of 8 patients with PROM1-related IRD, we identified 3 patients carrying the same variant (c.1354dupT) but expressing three different IRD phenotypes: Cone and rod dystrophy (CORD), Retinitis pigmentosa (RP), and Stargardt disease type 4 (STGD4). These three target patients, along with one healthy relative from each, underwent comprehensive ophthalmic examinations and their genetic panel study was expanded through clinical exome sequencing (CES). Subsequently, non-integrative patient-derived iPSC were generated and fully characterized. Correction of the c.1354dupT mutation was performed using CRISPR/Cas9, and the genetic restoration of the PROM1 gene was confirmed through flow cytometry and western blotting in the patient-derived iPSC lines. Results: CES revealed that 2 target patients with the c.1354dupT mutation presented monoallelic variants in genes associated with the complement system or photoreceptor differentiation and peroxisome biogenesis disorders, respectively. The pluripotency and functionality of the patient-derived iPSC lines were confirmed, and the correction of the target mutation fully restored the capability of encoding Prominin-1 (CD133) in the genetically repaired patient-derived iPSC lines. Conclusions: The c.1354dupT mutation in the PROM1 gene is associated to three distinct AR phenotypes of IRD. This pleotropic effect might be related to the influence of monoallelic variants in other genes associated with retinal dystrophies. However, further evidence needs to be provided. Future experiments should include gene-edited patient-derived iPSC due to its potential as disease modelling tools to elucidate this matter in question.

Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines

Establishment of Induced Pluripotent Stem Cell Line CSUASOi003- A from an Autosomal Recessive Retinitis Pigmentosa Patient Carrying Compound Heterozygous Mutations in CRB1 Gene

Using Inducible Lentiviral Vectors to Generate Induced Pluripotent Stem Cell Line ZOCi001-A from Peripheral Blood Cells of a Patient with CRB1-/- Retinitis Pigmentosa.

An induced pluripotent stem cell line (EHTJUi002-A) derived from a neonate with c.678G > A mutation in the gene <i>FZD4</i> causing exudative vitreoretinopathy

Generation of the human iPSC line ESi132-A from a patient with retinitis pigmentosa caused by a mutation in the PRPF31 gene

Generation of a Gene-Corrected Human Ipsc Line (Csuasoi004-a-1) from a Retinitis Pigmentosa Patient with Heterozygous C.2699 G>A Mutation in the PRPF6 Gene

Establishment of Non-Integrate Induced Pluripotent Stem Cell Line CSUASOi006-A, from Urine-Derived Cells of a PRPF8-related Dominant Retinitis Pigmentosa Patient

Establishment of Induced Pluripotent Stem Cell Line CSUASOi004-A by Reprogramming Peripheral Blood Mononuclear Cells of a PRPF6-related Dominant Retinitis Pigmentosa Patient.

Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5)

Generation of a gene-corrected isogenic human iPSC line (CSUASOi006-A-1) from a retinitis pigmentosa patient with heterozygous c.5792C > T mutation in the PRPF8 gene

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the <i>LMNA</i> gene by CRISPR/Cas9 technology

Generation and genetic repair of two human induced pluripotent stem cell lines from patients with Epidermolysis Bullosa simplex associated with a heterozygous mutation in the translation initiation codon of KLHL24

CRISPR/Cas9-mediated Generation of a Human Induced Pluripotent Stem Cell Line with PRPF6 C.2699 G > A Mutation to Model Retinitis Pigmentosa

Generation of an EYS-associated retinitis pigmentosa patient-derived human pluripotent stem cell line (MUi038-A)

Generation of a human induced pluripotent stem cell line UGENTi002-A from an arrhythmogenic cardiomyopathy patient carrying the c.817C>T DSP heterozygous variant and isogenic control using CRISPR/Cas9 editing

Generation of two induced pluripotent stem cell lines (LVPEIi007-B, LVPEIi008-B) from patients harboring homozygous mutation in ABCA4 (c.6088C>T) using non-integrative Sendai virus-based approach

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids from a Leber's Congenital Amaurosis Patient with Novel RPE65 Mutations.

Generation and characterization of a human iPSC line and gene-corrected isogenic line derived from a patient with a CELF2 gene mutation

Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes

Derivation of Induced Pluripotent Stem Cells Line (RCPCMi009-A-1) with Knockout of the UBE2A Gene by CRISPR/Cas9 Genome Editing